These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8897084)
1. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084 [TBL] [Abstract][Full Text] [Related]
2. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues. Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848 [TBL] [Abstract][Full Text] [Related]
3. Determination of Delta9-tetrahydrocannabinol from rabbit plasma by gas chromatography-mass spectrometry using two ionization techniques. Mannila J; Lehtonen M; Järvinen T; Jarho P J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):283-90. PubMed ID: 15380726 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous quantitation of delta-9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH) in serum by GC/MS using deuterated internal standards and its application to a smoking study and forensic cases. Moeller MR; Doerr G; Warth S J Forensic Sci; 1992 Jul; 37(4):969-83. PubMed ID: 1324293 [TBL] [Abstract][Full Text] [Related]
6. Effect of intrapulmonary tetrahydrocannabinol administration in humans. Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV. Fraser AD; Worth D Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects. Glaz-Sandberg A; Dietz L; Nguyen H; Oberwittler H; Aderjan R; Mikus G Clin Pharmacol Ther; 2007 Jul; 82(1):63-9. PubMed ID: 17410118 [TBL] [Abstract][Full Text] [Related]
9. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana. Harder S; Rietbrock S Int J Clin Pharmacol Ther; 1997 Apr; 35(4):155-9. PubMed ID: 9112136 [TBL] [Abstract][Full Text] [Related]
10. Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients. Frytak S; Moertel CG; Rubin J Cancer Treat Rep; 1984 Dec; 68(12):1427-31. PubMed ID: 6095996 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. Maralikova B; Weinmann W J Mass Spectrom; 2004 May; 39(5):526-31. PubMed ID: 15170748 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol. Lemberger L; Martz R; Rodda B; Forney R; Rowe H J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039 [TBL] [Abstract][Full Text] [Related]
13. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids. Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146 [TBL] [Abstract][Full Text] [Related]
15. [Interpretation of blood analysis data found after passive exposure to cannabis]. Toennes SW; Röhrich J; Wunder C Arch Kriminol; 2010; 225(3-4):90-8. PubMed ID: 20506708 [TBL] [Abstract][Full Text] [Related]
16. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. Teixeira H; Verstraete A; Proença P; Corte-Real F; Monsanto P; Vieira DN Forensic Sci Int; 2007 Aug; 170(2-3):148-55. PubMed ID: 17614225 [TBL] [Abstract][Full Text] [Related]
17. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Cirimele V; Villain M; Mura P; Bernard M; Kintz P Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544 [TBL] [Abstract][Full Text] [Related]
18. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein. Bonhomme-Faivre L; Benyamina A; Reynaud M; Farinotti R; Abbara C Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373 [TBL] [Abstract][Full Text] [Related]
19. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Curran HV; Brignell C; Fletcher S; Middleton P; Henry J Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420 [TBL] [Abstract][Full Text] [Related]
20. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]